/stocks — the workspaceLOADING
All ARWRSEC filings, by type → · Earnings date & implied move · Search inside filings
ARROWHEAD PHARMACEUTICALS, INC. (ARWR). Fundamentals from SEC filings; prices are end-of-day.
What’s behind ARWR’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
No recent 10-K / 10-Q / 8-K filings found.
Has ARWR been issuing shares? Offering history →
A plain-English read on ARWR plus an auto-SWOT — built from ARWR's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate ARWR using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
No tracked institution reported a position in ARWR in the latest 13F round.
No lawmaker has disclosed a trade in ARWR under the STOCK Act.
No open-market Form 4 buys or sells reported for ARWR in the last ~6 months.